Literature DB >> 6433710

Non-A, non-B hepatitis and chronic dialysis--another dilemma.

B J Seaworth, L E Garrett, W W Stead, J D Hamilton.   

Abstract

To define the incidence of non-A, non-B (NANB) hepatitis and evaluate possible risk factors, we reviewed records of 163 patients on chronic dialysis during a 3-year period. 23 cases of NANB hepatitis occurred, 13 (27%) in 49 center dialysis, 8 (10%) in 77 home hemodialysis (p less than 0.02) and 2 (5%) in 37 peritoneal dialysis patients (p less than 0.01). Hepatitis patients received significantly more transfusions than controls. Numbers of transfusions and of patients transfused were not significantly different in center patients compared to home and peritoneal. 8 NANB patients received no transfusions. NANB was the most common cause of hepatitis in our unit (68%). Although transfusions were a likely etiologic factor, to explain the increased risk in center dialysis patients, disease in patients not transfused and development of NANB hepatitis without a known parenteral exposure in a physician assigned to the Nephrology Service, we feel another etiologic factor was important, the dialysis center.

Entities:  

Mesh:

Year:  1984        PMID: 6433710     DOI: 10.1159/000166815

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  4 in total

1.  Hepatitis C infection in children and adolescents on haemodialysis and after renal transplant.

Authors:  M Greco; K Cristiano; G Leozappa; M Rapicetta; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

2.  Absence of hepatitis B and C viruses in pediatric idiopathic membranoproliferative glomerulonephritis.

Authors:  M J Nowicki; T R Welch; N Ahmad; I K Kuramoto; E C Mendoza; J B Zeldis; B M Baroudy; W F Balistreri
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

3.  Hepatitis C infection in hemodialysis units.

Authors:  S K Ha; J H Park; W C Choi; K H Kim; K H Choi; H Y Lee; D S Han; K S Song; H O Kim; S H Chung
Journal:  Korean J Intern Med       Date:  1990-07       Impact factor: 2.884

4.  Risk factors of HCV seroconversion in hemodialysis patients in tabriz, iran.

Authors:  Mohammad Hossein Somi; Jalal Etemadi; Morteza Ghojazadeh; Sara Farhang; Mehrasa Faramarzi; Sanaz Foroutan; Maryam Soleimanpour
Journal:  Hepat Mon       Date:  2014-06-01       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.